FDA Cleared
Discover the pioneering capabilities of DermaSensor’s breakthrough device, where innovation seamlessly integrates into practice. We empower physicians with AI-driven skin cancer assessment and a suite of essential functionalities to set your practice apart.
Uncover the seamless process of DermaSensor’s skin cancer assessment, offering clinicians valuable insights on lesions.
Explore DermaSensor’s groundbreaking technology – reliable information for physicians in assessing suspicious skin lesions, revolutionizing referral decisions.
A handheld, easy-to-use solution that fits seamlessly into the workflow of your clinical team.
An AI-powered platform to improve patient assessment and cancer diagnosis across your patient population.
A first-of-its-kind, streamlined skin cancer detection service at the point of care.
Meet the brilliant minds behind DermaSensor’s mission, where expertise converges to drive innovation in skin cancer detection. Get to know the faces shaping the future of healthcare and leading the charge in advancing medical technology.
Embark on a journey through DermaSensor’s rich history, tracing the evolution of our commitment to revolutionizing skin cancer detection. Discover pivotal milestones, breakthrough moments, and the relentless pursuit of excellence that defines our legacy in healthcare innovation.
Uncover the scientific foundation of DermaSensor through our extensive clinical studies, offering a meticulous exploration of the device’s effectiveness in skin cancer assessment. Dive into the robust evidence supporting DermaSensor’s role in advancing healthcare solutions.
Immerse yourself in DermaSensor’s world through our detailed brochures, providing a comprehensive overview of our innovative skin cancer detection technology. Explore the features, benefits, and applications that set DermaSensor apart in the realm of healthcare solutions.
hassle-free returns after 90 days. introductory offer: $199/Month (5 patients), or $399/Month (unlimited users & patients). Now Shipping
We’re currently not commercially available in your country. We’d love to keep you up to date on news by signing up for our newsletter.